Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics
A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the...